Seeking Alpha

In addition to raising its dividend by 34% this morning, Baxter International (BAX +2.9%) also...

In addition to raising its dividend by 34% this morning, Baxter International (BAX +2.9%) also approves a new $2B stock buyback program, as the health-care company looks to share the wealth and boost shareholder value. BAX has benefited recently on strong demand for its hemophilia and immunodeficiency products, and because of its product focus on life-threatening ailments and injuries, the company has been less impacted by the slowdown in health-care spending than its peers.
Comments (1)
  • johnhester
    , contributor
    Comment (1) | Send Message
     
    Any theories around as to why BAX directors allowed the company to get into the situation where they have a supply shortfall in plasma proteins? If they really wanted to boost shareholder value they would have invested in plant expansion 5 years ago to capitalise in the explosion of off label use.
    25 Jul 2012, 08:45 PM Reply Like
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector

Next headline on your portfolio:

|